cocaine dependence
Information
- Disease name
- cocaine dependence
- Disease ID
- DOID:9975
- Description
- "A drug dependence that is a psychological dependency on the regular use of cocaine." [url:http\://en.wikipedia.org/wiki/Cocaine_dependence]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04907357 | Active, not recruiting | N/A | rTMS for Stimulant Use Disorders | February 4, 2022 | July 2024 |
| NCT05562349 | Active, not recruiting | Phase 2 | Clavulanic Acid for the Treatment of Cocaine Use Disorder | May 3, 2023 | July 2024 |
| NCT00167232 | Completed | Phase 3 | Naltrexone in Two Models of Psychosocial Treatments for Cocaine and Alcohol Dependence | January 1998 | July 2003 |
| NCT00167245 | Completed | Phase 2 | Topiramate for Alcohol and Cocaine Dependence | September 2004 | June 2010 |
| NCT00167258 | Completed | Phase 2 | Effectiveness and Costs of Enhanced Cocaine Treatments | February 2007 | |
| NCT00218387 | Completed | Phase 2 | Modafinil Combined With Cognitive Behavior Therapy to Treat Cocaine Addiction - 1 | April 2004 | July 2010 |
| NCT00218491 | Completed | Phase 2 | Effectiveness of N-Acetylcysteine (NAC) in Treating Cocaine Dependent Individuals - 1 | November 2005 | May 2010 |
| NCT00218569 | Completed | Phase 2 | Combined Treatment for Cocaine-Alcohol Dependence - 1 | April 2003 | December 2007 |
| NCT00218660 | Completed | Phase 3 | Naltrexone in Two Models of Psychosocial Treatments for Cocaine and Alcohol Dependence - 1 | April 1998 | November 2007 |
| NCT00223210 | Completed | Phase 4 | An Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Cocaine Dependence | November 2005 | December 2007 |
| NCT00223236 | Completed | Phase 3 | Trial of Citicoline Therapy in Patients With Mania or Hypomania and Cocaine Abuse/Dependence | July 2010 | May 2012 |
| NCT00227123 | Completed | N/A | A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant Dependence | October 2002 | November 2006 |
| NCT00227812 | Completed | Phase 2 | Integrated Treatment for Cocaine and Mood Disorders - 1 | April 2001 | December 2005 |
| NCT00240110 | Completed | Phase 1/Phase 2 | Valproate Efficacy in Cocaine-Bipolar Comorbidity | March 2006 | March 2014 |
| NCT00249444 | Completed | Phase 2 | Mirtazapine for Treating Cocaine Dependent Individuals Who Also Suffer From Depression | May 2006 | December 2012 |
| NCT00249457 | Completed | N/A | Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 2 | October 1996 | January 2006 |
| NCT00249535 | Completed | N/A | Vouchers vs. Prizes for Cocaine-Dependent Methadone Patients - 2 | March 2005 | July 2011 |
| NCT00280293 | Completed | Phase 4 | Lamotrigine add-on Therapy for Bipolar Disorder and Cocaine Dependency | March 2006 | January 2010 |
| NCT00297505 | Completed | Phase 2 | Serotonin, Impulsivity, and Cocaine Dependence Treatment | April 2001 | November 2004 |
| NCT00322309 | Completed | Phase 2 | Efficacy of Mirtazapine in Depressed Cocaine Dependent Subjects | September 2005 | February 2010 |
| NCT00344565 | Completed | Phase 2 | A Placebo-Controlled Double-Blind Combined Treatment of Modafinil and CBT for Cocaine Dependence | November 2005 | March 2007 |
| NCT00368290 | Completed | Phase 2 | Modafinil Treatment for Cocaine Dependence and HIV High-Risk Behavior | September 2006 | January 2013 |
| NCT00368524 | Completed | N/A | Cost Effective Treatment for Dually Diagnosed Homeless | November 2001 | November 2005 |
| NCT01953432 | Completed | Phase 2 | Pharmacogenetic Trial of Doxazosin for Treatment of Cocaine Abuse | April 1, 2014 | October 1, 2017 |
| NCT00149630 | Completed | Phase 2 | Pharmacogenetics of Disulfiram for Cocaine | January 2005 | December 2009 |
| NCT01651364 | Completed | Phase 1 | A Pilot Study of Cabergoline for the Treatment of Cocaine Dependence | July 2011 | October 2011 |
| NCT01651377 | Completed | Phase 1 | Pramipexole as a Treatment for Cocaine Dependence | October 2011 | December 2012 |
| NCT01652378 | Completed | Pharmacologic MRI in Cocaine Addiction | August 2012 | August 2016 | |
| NCT01680887 | Completed | Phase 2 | A Phase II Trial of Varenicline for the Treatment of Cocaine Dependence | August 2012 | June 2019 |
| NCT01704196 | Completed | Phase 2 | A Multi-Center Trial of Nepicastat for Cocaine Dependence | April 2013 | December 2014 |
| NCT01778010 | Completed | Phase 2 | Modafinil for Smoked Cocaine Self-Administration | March 2009 | June 2013 |
| NCT01790490 | Completed | Phase 2 | Glutamatergic Modulation of Cocaine-related Deficits | February 2011 | March 2012 |
| NCT01811940 | Completed | Phase 2/Phase 3 | Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence | July 2013 | June 2017 |
| NCT01832649 | Completed | N/A | Exercise as an Adjunctive Treatment for Cocaine Dependent Patients | January 2012 | June 2012 |
| NCT01846481 | Completed | Phase 2 | A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse | April 2013 | June 2013 |
| NCT01906346 | Completed | Early Phase 1 | Impact of a Non-Drug Choice on Cocaine Reinforcement | January 2014 | June 2015 |
| NCT00061087 | Completed | Phase 2/Phase 3 | Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1 | February 1998 | October 2004 |
| NCT01963091 | Completed | Phase 2 | Effect of Oxytocin on Stress Response in Cocaine-dependent Individuals | July 2011 | October 2012 |
| NCT01978431 | Completed | Phase 1 | Impulsivity and Stimulant Administration | November 2012 | May 2014 |
| NCT01986075 | Completed | Phase 1/Phase 2 | A Sequenced Behavioral and Medication Intervention for Cocaine Dependence | January 2014 | January 2021 |
| NCT02018263 | Completed | Phase 1 | Validation of a Remote Wireless Sensor Network (WSN) Approach to the Individualized Detection of Cocaine Use in Humans | October 2013 | June 2014 |
| NCT02080819 | Completed | Phase 2 | Striatal Effective Connectivity to Predict Treatment Response in Cocaine Misuse | February 2014 | January 21, 2017 |
| NCT02080832 | Completed | Phase 2 | Brain Function and Structure in Cocaine Dependence | February 2010 | February 2016 |
| NCT02098434 | Completed | N/A | Ovarian Hormones and Stress Induced Drug Craving | October 2010 | July 2013 |
| NCT02111798 | Completed | Phase 2/Phase 3 | Bupropion-Enhanced Contingency Management (CM) for Cocaine Dependence | July 2014 | January 2021 |
| NCT02124941 | Completed | Phase 1 | Glutamate-Glutamine Cycling (VCYC) During Cocaine Abstinence Using 1H-MRS | February 2014 | August 14, 2022 |
| NCT02141620 | Completed | Early Phase 1 | n-Acetylcysteine and Cocaine | May 2014 | April 2016 |
| NCT02181491 | Completed | N/A | PET Imaging in Cocaine Self Administration | July 2014 | December 2019 |
| NCT02255357 | Completed | Phase 2/Phase 3 | Investigation of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients. | March 2015 | February 14, 2018 |
| NCT02302976 | Completed | Phase 1 | GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration | November 2014 | August 1, 2018 |
| NCT02416050 | Completed | Predicting Relapse After Cocaine Inpatient Cessation | February 3, 2015 | January 3, 2022 | |
| NCT02538744 | Completed | Phase 1 | Complementary Combination Therapy for Cocaine Dependence | August 2015 | August 21, 2018 |
| NCT02559167 | Completed | Phase 2 | Cannabidiol and Cocaine Craving/Dependence | July 1, 2016 | August 16, 2019 |
| NCT02563769 | Completed | Phase 1 | Clavulanic Acid (CLAV) and Cocaine Interaction Safety Study | October 24, 2016 | May 25, 2018 |
| NCT02596022 | Completed | Phase 2 | The Effect of Glutamatergic Modulation on Cocaine Self-administration | June 2013 | July 2015 |
| NCT02774954 | Completed | N/A | Change the Cycle: An RCT to Prevent Injection Initiation | June 2016 | November 2019 |
| NCT02994875 | Completed | Early Phase 1 | Functional Magnetic Resonance Imaging of N-acetylcysteine in Cocaine Dependence | May 2016 | September 2020 |
| NCT03238859 | Completed | Phase 2 | 10 Days of Theta Burst Stimulation as a Tool to Treat Cocaine Dependence | August 1, 2016 | June 7, 2019 |
| NCT03349606 | Completed | Early Phase 1 | Cocaine Use Disorder and Cortical Dopamine | June 2, 2010 | June 1, 2020 |
| NCT03471182 | Completed | Phase 1 | Investigation of Cocaine Addiction Using mGluR5 PET and fMRI | February 26, 2018 | August 18, 2022 |
| NCT03527485 | Completed | N/A | Imaging Synaptic Density in Cocaine and Opiate Addiction In Vivo Using 11UCB-J PET | January 1, 2019 | March 28, 2023 |
| NCT03554928 | Completed | Longitudinal Assessment of Functional Connectivity in Treatment Engaged Cocaine Users | August 1, 2015 | June 9, 2019 | |
| NCT03662529 | Completed | N/A | Neurobehavioral Measurement of Substance Users in Outpatient Treatment Setting | June 5, 2017 | February 1, 2018 |
| NCT03921151 | Completed | Phase 1/Phase 2 | 5HT2CR Balance in Brain Connectivity in Cocaine Dependence | May 13, 2014 | January 24, 2019 |
| NCT04411914 | Completed | Phase 1 | Pharmaco-Magnetic Resonance Spectroscopy (MRS) Study of Clavulanic Acid | September 1, 2020 | March 31, 2022 |
| NCT00376558 | Completed | N/A | Imaging the Neurobiology of a Behavioral Treatment for Cocaine Dependence | July 2006 | January 2011 |
| NCT00385268 | Completed | Phase 2 | Pilot Trial of Acamprosate for the Treatment of Cocaine Dependence | November 2006 | July 2008 |
| NCT00385801 | Completed | Phase 2 | Study of the Effects of Risperdal Consta on Brain Reward Circuitry Function, Craving and Cocaine Use in Active Cocaine Dependence | September 2005 | September 2010 |
| NCT00395850 | Completed | Phase 2 | Disulfiram for Cocaine Abuse | April 2007 | December 2011 |
| NCT00421603 | Completed | Phase 2 | A Placebo-Controlled Study of Mixed Amphetamine Salts and Topiramate for the Treatment of Cocaine Dependence | February 2007 | May 2010 |
| NCT00451230 | Completed | N/A | Metabolic Effects of Cocaine | June 2005 | June 2005 |
| NCT00527683 | Completed | Phase 2 | Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence | April 2007 | November 2007 |
| NCT00553319 | Completed | Phase 2/Phase 3 | Study of Adderall-XR for the Treatment of Adult Attention Deficit Hyperactivity Disorder and Cocaine Dependence | December 2007 | July 2013 |
| NCT00566969 | Completed | N/A | Cocaine Withdrawal and Pharmacotherapy Response | September 2007 | January 2013 |
| NCT00567008 | Completed | Phase 2 | Chantix for Treating Cocaine Dependence | December 2007 | September 2009 |
| NCT00567320 | Completed | N/A | Efficacy of Varenicline in Methadone-Stabilized Cocaine Users | March 2007 | August 2009 |
| NCT00567814 | Completed | N/A | A Placebo-Controlled Study of a Combination of Metyrapone and Oxazepam in Cocaine Addiction | December 2007 | November 2008 |
| NCT00577005 | Completed | Phase 2 | Efficacy of Levetiracetam in Cocaine-Abusing Methadone Maintained Patients | July 2007 | October 2008 |
| NCT00582491 | Completed | N/A | Modafinil, Sleep, and Cognition in Cocaine Dependence | August 2006 | February 2009 |
| NCT00585520 | Completed | Phase 1 | Sex Differences in Progesterone Effects on Responses to Stress and Drug Cues | September 2007 | September 2013 |
| NCT00593125 | Completed | Phase 2 | Levetiracetam (Keppra) Tolerability in Cocaine Abusing Methadone-maintained Patients. | January 2007 | August 2008 |
| NCT00606853 | Completed | N/A | Enhanced and Attendance-based Prize CM in Community Settings | October 2003 | April 2009 |
| NCT00611130 | Completed | Phase 2 | Vigabatrin for Treatment of Cocaine Dependence | January 2008 | October 2012 |
| NCT00619723 | Completed | Phase 4 | Citicoline for Bipolar 1 Disorder and Cocaine Dependence | April 2008 | April 2012 |
| NCT00631748 | Completed | N/A | Quetiapine for the Reduction of Cocaine Use | February 2008 | July 2010 |
| NCT00632099 | Completed | Phase 2/Phase 3 | Progesterone Treatment for Cocaine-dependent Women: A Pilot Study | February 2008 | September 2012 |
| NCT00654953 | Completed | Phase 2 | Clinical Efficacy of Sertraline Augmented With Gabapentin in Depressed, Recently Abstinent Cocaine-dependent Humans | January 2006 | May 2009 |
| NCT00656357 | Completed | Phase 1/Phase 2 | Study of Safety and Potential Efficacy of SYN117 in Cocaine Dependent Volunteers | June 2008 | May 2009 |
| NCT00685178 | Completed | Phase 2 | Clinical Trial of Topiramate for Cocaine Addiction | February 2007 | September 2011 |
| NCT00685659 | Completed | N/A | Effectiveness of Extended Treatments for Drug Dependence | May 2007 | December 2011 |
| NCT00689572 | Completed | Phase 2 | New Medication Treatment for Stimulant Dependence | July 2008 | December 2013 |
| NCT00697138 | Completed | Phase 1 | Agonist Replacement Therapy for Cocaine Dependence | June 2006 | January 2012 |
| NCT00701532 | Completed | Phase 3 | Brain Imaging Study of the Effects of Modafinil in Cocaine Addiction | April 2009 | January 2013 |
| NCT00713583 | Completed | Phase 2 | Carbidopa/Levodopa Combined With Behavioral Therapy for the Treatment of Cocaine Dependence | January 2008 | December 2011 |
| NCT00732901 | Completed | Phase 2/Phase 3 | Clinical Neurobiology of Serotonin and Addiction | June 2008 | February 2013 |
| NCT00733993 | Completed | Phase 1/Phase 2 | Caffeine and Cocaine | April 2008 | October 2011 |
| NCT00744601 | Completed | Impulsivity, Neural Deficits and Cocaine Addiction | April 2007 | September 2012 | |
| NCT00756925 | Completed | Gender and Neural Substrates of Stress and Craving | February 2009 | August 2010 | |
| NCT00777062 | Completed | Phase 2 | VIVITROL as a Treatment for Cocaine and Alcohol Dependence | July 2009 | September 2013 |
| NCT00780702 | Completed | Phase 1 | Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients | May 8, 2008 | April 16, 2013 |
| NCT00783276 | Completed | Early Phase 1 | An fMRI Study of SYN115 in Cocaine Dependent Subjects | October 2008 | January 2013 |
| NCT00808119 | Completed | Phase 1 | Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of RTI-336 in Healthy, Male Subjects | October 2008 | March 2009 |
| NCT00809835 | Completed | Phase 2 | Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse | December 2007 | January 2015 |
| NCT00830362 | Completed | Phase 2 | Beta-blockade Effects on Memory for Cocaine Craving | February 2009 | July 2011 |
| NCT00838981 | Completed | Phase 1/Phase 2 | Pharmacotherapy & CM for Opioid and Cocaine Dependence | May 2008 | March 2014 |
| NCT00842517 | Completed | Phase 1 | Long Term Maintenance of Drug Abstinence | September 2004 | August 2008 |
| NCT00880997 | Completed | Phase 1 | The Efficacy of Doxazosin for Cocaine Users | September 2009 | December 2011 |
| NCT00913484 | Completed | Phase 2 | Disulfiram for Cocaine Abuse in Buprenorphine Treatment | October 2000 | February 2004 |
| NCT00914381 | Completed | Phase 2 | Behavioral Treatment for Cocaine Dependent Women | December 1994 | March 2002 |
| NCT00958282 | Completed | Phase 2 | Treatment of Cocaine Dependence With Lisdexamfetamine | July 2009 | January 2013 |
| NCT00965263 | Completed | Phase 2 | Therapeutic Cocaine Vaccine: Human Laboratory Study | March 2003 | August 2009 |
| NCT00969878 | Completed | Phase 2 | Multisite Controlled Trial of Cocaine Vaccine | August 2010 | July 2014 |
| NCT00969943 | Completed | Gender Differences in Response to Cues in Cocaine Dependence | March 2003 | August 2007 | |
| NCT01030692 | Completed | Phase 1 | Rivastigmine and Huperzine A as Treatments for Cocaine Dependence | January 2009 | June 2014 |
| NCT01031563 | Completed | Risk Perception in Drug-Dependent Adults With and Without Schizophrenia | August 18, 2009 | May 3, 2012 | |
| NCT01036074 | Completed | Reward Processing in Cocaine Addiction | March 17, 2005 | April 8, 2013 | |
| NCT01036516 | Completed | PET Assays of Striatal Dopamine Marker in Cocaine Craving | June 23, 1998 | March 27, 2012 | |
| NCT01038232 | Completed | Measuring Distress Tolerance With Functional MRI | December 4, 2009 | March 24, 2015 | |
| NCT01062945 | Completed | Phase 1 | The Effects of Doxazosin on the Cardiovascular and Subjective Effects of Cocaine | January 2010 | January 2011 |
| NCT01077024 | Completed | Phase 3 | Smoking-Cessation and Stimulant Treatment (S-CAST) | February 2010 | August 2012 |
| NCT01134198 | Completed | Phase 2/Phase 3 | Investigation of Mifepristone (RU486) on Stress Sensitivity and Relapse Prevention in Cocaine Dependent Patients | May 2010 | February 14, 2018 |
| NCT01137396 | Completed | Phase 2 | Modafinil, Sleep Architecture and Cocaine Relapse | April 2010 | February 2015 |
| NCT01137890 | Completed | Phase 1/Phase 2 | Effect of Zonisamide on Cocaine Reinforcement, Craving, and Relapse | June 2010 | August 2013 |
| NCT01145183 | Completed | Phase 2 | Pharmacogenetics of Doxazosin for Cocaine Dependence | March 2010 | September 2015 |
| NCT01151813 | Completed | Phase 2 | Human Behavioral Pharmacology Laboratory (HBPL) Study of Varenicline's Impact on Cocaine and Alcohol Craving | July 2010 | December 2013 |
| NCT01153464 | Completed | Phase 2 | Effectiveness of Extended Treatment for Drug Dependence (ETDD) in the City Study | October 2009 | September 2011 |
| NCT01153477 | Completed | Phase 2 | Effectiveness of Enhanced Treatments for Drug Dependence | October 2009 | October 2011 |
| NCT01171183 | Completed | Phase 2 | Carvedilol for Psychostimulant Dependence | August 2010 | May 2014 |
| NCT01176591 | Completed | Phase 2 | HBPL Study of the Impact of the NK1 Antagonist Aprepitant | September 2010 | December 2013 |
| NCT01249274 | Completed | N/A | Progesterone for Postpartum Cocaine Relapse | February 2011 | July 2013 |
| NCT01251393 | Completed | Phase 3 | Cocaine/Crack and Reduction of Compulsion With Biperiden | May 2011 | November 2012 |
| NCT01267292 | Completed | Phase 2 | Psychopharmacology for Cocaine Dependence - Buspirone | March 2011 | December 2015 |
| NCT01281202 | Completed | Phase 2/Phase 3 | Vigabatrin for the Treatment of Cocaine Dependency | January 2011 | December 2012 |
| NCT01283191 | Completed | N/A | Behavioral Incentives to Increase Exercise in Cocaine Dependent Women | May 2012 | August 2013 |
| NCT01327586 | Completed | Phase 2 | Abstinence-Linked Money Management Multisite | December 2009 | January 2014 |
| NCT01377662 | Completed | Phase 2 | PHASE IIA: Trial of a Novel Ondansetron Formulation (OND-PR002) and Immediate-Release Methylphenidate (Ritalin®)(OND003IND) | August 2011 | May 2013 |
| NCT01393457 | Completed | Phase 2 | Cognitive Remediation for Cocaine Dependence | June 2011 | February 2017 |
| NCT01402492 | Completed | Phase 2/Phase 3 | Cocaine Use Reduction With Buprenorphine | September 2011 | March 2013 |
| NCT01468012 | Completed | Phase 2/Phase 3 | Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine Dependence | July 2014 | December 2015 |
| NCT01486810 | Completed | Phase 1/Phase 2 | Open-Label Pilot Study of Lisdexamfetamine for Cocaine Dependence | December 2011 | December 2013 |
| NCT01535573 | Completed | Phase 2 | Citalopram for Cocaine Dependence | December 2010 | July 2016 |
| NCT01558973 | Completed | FMRI of Stress and Addictive Disorders | August 2005 | ||
| NCT01573273 | Completed | N/A | Oxytocin in Cocaine Dependence | October 2012 | December 19, 2017 |
| NCT01601730 | Completed | Phase 1 | Modafinil - Escitalopram Study for Cocaine Dependence | August 2010 | July 2011 |
| NCT01601743 | Completed | N/A | Exercise as a Behavioral Treatment for Cocaine Dependence | September 2011 | July 2014 |
| NCT01641159 | Completed | Phase 2 | Study of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence | August 2012 | June 2013 |
| NCT05974202 | Not yet recruiting | Phase 2 | rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder | September 15, 2024 | September 2026 |
| NCT05824221 | Not yet recruiting | N/A | Effect of rTMS on Neurotrophines Levels in CUD | April 30, 2023 | October 31, 2023 |
| NCT06159387 | Recruiting | Phase 4 | Randomized, Double-blind, Placebo-controlled Cannabis Extract x Placebo for Cocaine Addicts | October 23, 2023 | October 23, 2025 |
| NCT05857852 | Recruiting | N/A | Low-Intensity Focused Ultrasound for Cocaine Use Disorder | March 1, 2023 | March 1, 2025 |
| NCT00439049 | Recruiting | Substance Abuse Pre-Treatment Screening Study | October 2005 | June 2026 | |
| NCT02927236 | Recruiting | Phase 4 | Theta-Burst Stimulation as a Treatment for Reducing Cocaine Use | February 13, 2017 | December 31, 2024 |
| NCT02455479 | Recruiting | Phase 1 | Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals | June 26, 2012 | June 2025 |
| NCT06189690 | Recruiting | N/A | Effect of HF rTMS on Serum BDNF in Cocaine Use Disorder | January 6, 2022 | December 1, 2027 |
| NCT06125054 | Recruiting | Phase 2 | Ketamine and Neurofeedback-Training: Effects on Neuroplasticity in Cocaine Addiction | February 5, 2024 | March 2026 |
| NCT01431586 | Terminated | Phase 1 | First in Humans Study of JDTic | ||
| NCT01938664 | Terminated | Phase 2 | A Pilot Study of Candesartan as a Treatment for Cocaine Dependence | January 2013 | July 2016 |
| NCT01490216 | Terminated | Phase 1 | Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence | July 2011 | January 2013 |
| NCT00373581 | Terminated | Phase 2 | Effects of Vigabatrin on Cocaine Self-Administration | April 2006 | December 2006 |
| NCT01535937 | Terminated | Phase 1/Phase 2 | The Effect of Brief Potent Glutamatergic Modulation on Cocaine Dependence | February 2012 | April 2017 |
| NCT01335867 | Terminated | Phase 2 | Vigabatrin for Cocaine and Alcohol Dependence | April 2011 | December 2013 |
| NCT02935101 | Terminated | Phase 2 | Effects of Glucocorticoids on Craving During Detoxification Treatment of Heroin and/or Stimulants | October 2016 | May 2017 |
| NCT00688805 | Terminated | Phase 1 | Effects of Propranolol on Responses to Drug-Related Imagery Scripts | December 12, 2007 | December 16, 2013 |
| NCT02152670 | Terminated | N/A | Understanding Dopamine Mechanisms in Cocaine Addiction Using AMPT and Methylphenidate With [11C]RAC/[11C]PHNO PET | May 2014 | June 9, 2014 |
| NCT01802515 | Terminated | N/A | A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance Treatment | December 2012 | March 2014 |
| NCT00951314 | Terminated | Brain Glutamate Receptors and Cocaine Dependence | July 14, 2009 | March 19, 2013 | |
| NCT00240227 | Terminated | N/A | Prazosin for ETOH or Cocaine Craving | April 2004 | January 2009 |
| NCT00599573 | Unknown status | N/A | Pharmacotherapy for HIV+ Stimulant Dependent Individuals | October 2007 | December 2010 |
| NCT03266939 | Unknown status | Phase 1 | Rebalancing the Serotonergic System in Cocaine Dependence | October 4, 2018 | December 2021 |
| NCT03333460 | Unknown status | N/A | Transcranial Magnetic Stimulation for Cocaine Addiction | October 1, 2017 | December 1, 2020 |
| NCT01822327 | Unknown status | Phase 2 | Treating Cocaine Abuse: A Behavioral Approach | December 2007 | March 2014 |
| NCT00448825 | Unknown status | Phase 3 | Novel Pharmacotherapy for Dual Dependence | March 2007 | June 2013 |
| NCT00123383 | Unknown status | Phase 2 | Randomised Placebo-Controlled Trial of Modafinil for Cocaine Dependence | July 2005 | September 2007 |
| NCT00495183 | Unknown status | Phase 4 | Efficacy of Caffeine, With and Without Biperiden, as a Maintenance Treatment for Cocaine Dependence | January 2009 | July 2010 |
| NCT01397266 | Unknown status | Phase 2 | Study of the Effect of Magnetic Stimulation Repetitive Transcranial on Impulsivity in Cocaine Dependence | March 2010 | July 2013 |
| NCT01914835 | Unknown status | N/A | Neuropsychological Rehabilitation on Cocaine/Crack Dependents | April 2011 | October 2017 |
| NCT03833583 | Unknown status | N/A | tDCS to Reduce Craving in Cocaine Addiction | February 1, 2019 | September 30, 2019 |
| NCT01593982 | Unknown status | Phase 2 | Repetitive Transcranial Magnetic Stimulation in Symptoms of Attention Deficit Hyperactivity Disorder and Cognitive Function In Cocaine Addicts | March 2010 | March 2013 |
| NCT04994821 | Unknown status | Phase 2 | tDCS to Reduce Craving in Cocaine Addiction- Phase 2 Study | September 28, 2020 | September 2022 |
| NCT00737256 | Unknown status | Phase 2 | A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence | August 2008 | May 2014 |
| NCT01406522 | Withdrawn | Phase 2 | Tacrine Effects on Cocaine Self-Administration and Pharmacokinetics | October 2012 | November 2013 |
| NCT01715051 | Withdrawn | Phase 2 | D-Serine for Cocaine Dependence Pilot | February 2014 | September 2019 |
| NCT02134002 | Withdrawn | Phase 4 | A PET Exploration of the Mechanism of Action of Dopamine Beta-hydroxylase Inhibition in Cocaine Addicts | June 2014 | December 2016 |
| NCT01741376 | Withdrawn | N/A | Progesterone and Atomoxetine for Cocaine Cessation | November 2012 | November 2012 |
| NCT01143857 | Withdrawn | Phase 2 | Human Behavioral Pharmacology Laboratory Study of Varenicline's Impact on Cocaine Reinforcement | June 2010 | August 2013 |
| NCT02003664 | Withdrawn | Phase 2 | A Study of Baclofen ER | November 2013 | November 2014 |
- Disase is a (Disease Ontology)
- DOID:9974
- Cross Reference ID (Disease Ontology)
- ICD10CM:F14.2
- Cross Reference ID (Disease Ontology)
- ICD9CM:304.2
- Cross Reference ID (Disease Ontology)
- MESH:D019970
- Cross Reference ID (Disease Ontology)
- NCI:C34492
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:286934009
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0600427